Clinical Trial: CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Lymphoblastic Leukemia
Study Type: INTERVENTIONAL
Official Title: A Single-Arm, Open-Label Phase 1b Study of Hyper-CVAD + Calaspargase Pegol in Young Adults With Newly Diagnosed Acute Lymphoblastic Leukemia
Brief Summary:
The purpose of the study is to evaluate the safety and tolerability of the study drug, calaspargase pegol, when given with multi-agent chemotherapy.
Read more